Flordis CAM Update

Flordis has issued a statement aiming to address “a number of misleading statements” regarding the use of complementary and alternative medicines (CAMs) for the treatment of menopause symptoms.  In particular, SOHO Flordis CEO Nigel Pollard strongly disagreed with a sweeping conclusion in a paper published in the Medical Journal of Australia which said CAMs for alleviating vasomotor symptoms “are known to be ineffective”.

He said the Monash University paper did not investigate the clinical efficacy of any individual natural medicine, yet asserted that all such products were useless based on ‘other metaanalysis reviews and quality of life questionnaire responses”.  Pollard said the meta-analysis of natural medicine studies does not take into account the wide variability of the products, simply lumping all such items together.  “Any study which treats all natural products as equal, such as the Monash publication or indeed a Cochrane review, is not appropriate for drawing any inferences on an individual product or treatment”.

Source:pharmacydaily.com.au, Friday 7 August 2015